Brief: Biogen Q3 Adjusted EPS USD 2.62 Vs. IBES Estimate USD 1.99
BRIEF-Biogen Q3 Adjusted EPS USD 2.62 Vs. IBES Estimate USD 1.99 Oct 28 (Reuters) - Biogen Q3 EPS USD -0.14.
- Q3 revenue USD 2,800 million vs. IBES estimate USD 2,634 million
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova